Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

NCT01131169 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: busulfan, melphalan and fludarabine
DRUG: busulfan, melphalan and fludarabine

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]